Previous 10 |
Australia's Immutep (NASDAQ: IMMP ) is up 11.4% after hours in U.S. trading after it announced more mature data from an ongoing TACTI-mel Phase I clinical trial. More news on: Immutep Limited ADR, Healthcare stocks news, Stocks on the move, Global news and forex, Read more ...
Gainers: IMMP +12.3% . AMBA +7.9% . AVAV +7.5% . AGS +4.3% . AFH +4.1% . More news on: Immutep Limited ADR, Ambarella, AeroVironment, Inc., Stocks on the move, Read more ...
SYDNEY, Australia, March 04, 2019 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (Immutep or the Company), a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune diseases, today announced its participation in Oppenheimer’s 29th Annua...
SYDNEY, Australia, Feb. 27, 2019 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (Immutep or the Company), a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune diseases, today announced its participation in various upcoming industry confer...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
1.55%Change Percent:
Immutep Limited Company Name:
IMMP Stock Symbol:
NASDAQ Market:
Immutep Limited Website:
Media Release Final discussion with the FDA, successfully concluding the regulatory preparations for the TACTI-004 Phase III trial design to evaluate efti in combination with KEYTRUDA ® (pembrolizumab), MSD’s anti-PD-1 therapy, and standard chemotherapy in first-...
Media Release Study expected to enrol first participants during Q3 CY2024 SYDNEY, AUSTRALIA, July 17, 2024 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a clinical-stage biotechnology company developing no...
2024-07-12 10:45:04 ET QuantumScape Corp (QS) QS is trading UP for the last 5 days, and it at trading at $7.84 with volume of 22,322,158 and a one day change of $0.78 (10.98%). QuantumScape Corp has a 52-week low of 4.67 and a 52-week high of $13.86. The business's 50-day moving ave...